GEORGIA JURISPRUDENCE &
LAST MINUTE CE 

The GOA will be offering its last chance for Georgia Jurisprudence and four hours of Georgia State Board of Optometry Approved Continuing Education on Friday, December 8, 2017 in their Atlanta office . 

There will be two jurisprudence classes to choose from:
10:00 a.m. - 11:00 a.m. or 11:30 a.m. - 12:30 p.m.  

The four hours of Georgia State Board of Optometry Approved Continuing Education will begin at 1:00 p.m. and conclude at 4:30 p.m.

Registrants can choose to take Jurisprudence Only, CE Only or All Classes for that day.  For those electing the All Classes or Afternoon CE, lunch will be provided. 

Courses for this day are as follows: 

Georgia Jurisprudence
(1hr Non-COPE) Georgia State Board of Optometry Approved CE
Lecturer: Aubrey Villines, GOA General Counsel

What does the law say when it comes to patient rights? Is your practice complying too those statutes?  How does your scope of practice play a part? This is a great opportunity to hear an attorney’s perspective, which will have your best interest in mind in when it comes to compliance to patient and practice care.

Don't Get Fooled When the OCT Goofs
(2hrs Non-COPE) Georgia State Board of Optometry Approved CE
Lecturer: Benjamin Casella, O.D. 

Spectral domain optical coherence tomography SD-OCT has truly revolutionized diagnosis and management of many ocular diseases.  However, these devices do not diagnose diseases of directly measure tissues but only measure differences in optical reflectivity. This course will highlight several cases in which lurking variables have skewed OCT values, thus potentially misleading the clinician. The course will be presented through a rapid-fire grand rounds format. 

Whats New With Glaucoma
(2hrs Non-COPE) Georgia State Board of Optometry Approved CE 
Lecturer: Benjamin Casella, O.D. 

This course will describe several contemporary concepts regarding glaucoma as a multifactorial neurodegenerative disease. Current diagnostic considerations will be presented through clinical case examples, and possible emerging therapies, including the concept of neuroprotection, will be explained through use of recent studies on glaucoma models.